Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Revıew Article Volume 7 Issue 10

Relationship between Vitamin D Deficiency and Covid-19

Mehtap Tınazli and Gaukhar Bakhtiyarova*

Near East University Hospital, School of Medicine, Department of Endocrinology and Internal Medicine, Turkish Republic of Northern Cyprus, Nicosia

*Corresponding Author: Gaukhar Bakhtiyarova, Near East University Hospital, School of Medicine, Department of Endocrinology and Internal Medicine, Turkish Republic of Northern Cyprus, Nicosia.

Received: July 17, 2023; Published: September 29, 2023


As we all know, a new coronavirus was detected in Wuhan, China in December 2019. Patients infected with 2019-nCoV, later named SARS-Cov-2, were reported to have fever, cough, fatigue, and shortness of breath. The novel coronavirus severe acute respiratory syndrome (SARS-CoV-2) has rapidly progressed from an epidemic to a global pandemic, with new variants rapidly emerging. Because of the highly contagious and deadly nature of the virus, finding effective treatments was a top priority and a global pandemic was declared by the World Health Organization (WHO) on 11 March.

Vitamin D is an immunomodulatory hormone with proven efficacy against various upper respiratory tract infections. Vitamin D may be protective against acute respiratory infections as it modulates the inflammatory cytokine response of respiratory epithelial cells and macrophages, suppressing CS and other manifestations seen in SARS-Cov-2. Therefore, it is recommended as one of the treatment options in SARS-CoV-2 infection. In 20 European countries, low vitamin D levels were observed in cases of COVID-19 with a higher incidence of mortality, increased risk of death during disease severity, need for intensive care and even Covid-19 infection contributing to ARDS or fulminant myocarditis.

In this review, it was aimed to investigate the role of vitamin D in the prevention and treatment of the severe course of COVID-19. While there have been some conflicting results reported, the consensus is that vitamin D has a number of immunomodulatory effects that may be beneficial in the context of COVID-19, and that low levels of vitamin D can cause and potentially contribute to dysfunction of significant antimicrobial effects.

In addition, some studies show that the effects of vitamin D deficiency can be alleviated by supplementation, and vitamin D supplementation is recommended in Covid-19 infection because it is inexpensive, easy to use and safe.

 Keywords: Coronavirus; SARS-Co-V-19; Vitamin D; Immune System; COVID-19; Infection; Review


  1. Azrielant S and Shoenfeld Y. “Vitamin D and the immune system”. The Israel Medical Association Journal 8 (2017): 510-511.
  2. Holick MF. “The vitamin D deficiency pandemic: approaches for diagnosis,treatment and prevention”. Reviews in Endocrine and Metabolic Disorders 18 (2017): 153-165.
  3. Ali N. “Role of vitamin D in preventing of COVID-19 infection, progression and severity”. Journal of Infection and Public Health 13 (2020): 1373-1380.
  4. Dankers W., et al. “Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential”. Frontiers in Immunology 7 (2017):
  5. Infante M., et al. “Influence of vitamin d on islet autoimmunity and beta-cell function in type 1 diabetes”. Nutrients 11 (2019):
  6. Bouillon R., et al. “Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions”. Endocrine Reviews 40 (2019): 1109-1151.
  7. Pereiraa M., et al. “Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis”. Crıtıcal Revıews ın Food Scıence and Nutrıtıon5 (2022): 1308-1316.
  8. Speeckaert MM and Delanghe JR. “Association between lowvitamin D and COVID-19: Don’t forget the vitamin D binding protein”. Aging Clinical and Experimental Research7 (2020): 1207-1208.
  9. Whittemore PB. “COVID-19 fatalities, latitude, sunlight, andvitamin D”. American Journal of Infection Control 9 (2020): 1042-1044.
  10. Daneshkhah A., et al. “The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients”. Infectious Diseases (except HIV/AIDS) (2020).
  11. Darling AL., et al. “Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)”. Infectious Diseases (except HIV/AIDS) (2020).
  12. De Smet D., et al. “Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics”. Infectious Diseases (except HIV/AIDS) (2020).
  13. Glicio EJ. “Vitamin D level of mild and severe elderly cases of COVID-19: a preliminary report (2020).
  14. Hastie CE., et al. “Vitamin D concentrations and COVID-19 infection in UK Biobank”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 14 (2020): 561-565.
  15. Ilie PC., et al. “The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality”. Aging Clinical and Experimental Research (2020).
  16. Lau FH., et al. “Vitamin D insufficiency is prevalent in severe COVID-19”. Infectious Diseases (except HIV/AIDS) (2020).
  17. Li Y., et al. “Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States (preprint, in review) (2020).
  18. Raharusun P., et al. “Patterns of COVID-19 mortality and vitamin D: an Indonesian study”. SSRN Journal (2020).
  19. Mohan M., et al. “Exploring links between vitamin D deficiency and COVID-19”. Plos Pathogens (2020).
  20. Alberca RW., et al. “Obesity as a risk factor for COVID-19: An over-view”. Critical Reviews in Food Science and Nutrition (2020).
  21. de Oliveira LF., et al. “Obesity and overweight decreases theeffect of vitamin D supplementation in adults: Systematic reviewand meta-analysis of randomized controlled trials”. Reviews in Endocrine and Metabolic Disorders 21 (1 (2020): 67-76.
  22. Akbar Anaeigoudari., et al. “Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System”. Inflammation6 (2021).
  23. Ahmet Kursat Azkur., et al. “Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Review article”. Allergy 75 (2020): 1564-1581.
  24. Joachim L Schultze and AnnaC Aschenbrenner. “COVID-19 and the human innate immune system. Review”. Cell 184 (2021).
  25. , et al. “Immunology of COVID-19: current state of the science”. Immunity (2020).
  26. Zhai Yanfang Chenguang Wang and Zhengfan Jiang. “Crosstalk between bacterial PAMPs and host PRRs”. National Science Review 5 (6 (2018): 791-792.
  27. Amarante-Mendes., et al. “Pattern recognition receptors and the host cell death molecular machinery”. Frontiers in Immunology 9 (2018): 2379.
  28. Ming-Yieh Peng., et al. “Review Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D”. International Journal of Molecular Sciences 22 (2021):
  29. IstvánVályi-Nagy., et al. “Review Adaptive Immunity to Viruses: What DidWe Learn from SARS-CoV-2 Infection?” International Journal of Molecular Sciences 23 (2022):
  30. Bhaskar S., et al. “Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper”. Frontiers in Immunology 11 (2020): 1648.
  31. Wong LR and Perlman S. “Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses-Are we our own worst enemy?” Nature Reviews Immunology 22 (2022): 47-56.
  32. Lee S., et al. “Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines”. Trends in Immunology 41 (2020): 1083-1099.
  33. Annweiler C., et al. “Covid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial”. Trials 1 (2020): 1031.
  34. Angelidi AM., et al. “Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients”. Mayo Clinic Proceedings 4 (2021): 875-886.
  35. National Heart L., et al. “Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients”. The New England Journal of Medicine 26 (2019): 2529-2540.
  36. Rastogi A., et al. “Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)”. Postgraduate Medical Journal (2020).
  37. Zdrenghea MT., et al. “Vitamin D modulation of innate immune responses to respiratory viral infections”. Reviews in Medical Virology 1 (2017).
  38. Shi Y., et al. “Chronic vitamin D deficiency induced lung fibrosis through activation of the reninangiotensin system”. Scientific Reports 1 (2017): 3312.
  39. McKenna MJ and Murray B. “Vitamin D deficiency”. Endocrinology and diabetes: A problem-oriented approach. Springer New York (2014): 293-304.
  40. Zhou YF., et al. “The association between Vitamin D deficiency and community-acquired pneumonia: A metaanalysis of observational studies”. Medicine (Baltimore)38 (2019): e17252.
  41. Ainine A., et al. “Vitamin D and COVID-19 Infection”. Medical Journal of Malaysia 6 (2021): 881-883.
  42. National Diet and Nutrition Survey Results from Years 1, 2, 3 and 4 (combined) of the Rolling Programme (2008).
  43. Khan AS., et al. “Vitamin D and COVID-19: is there a role?” Journal of Diabetes and Metabolic Disorders 20 (2021): 931-938.
  44. Konijeti GG., et al. “Vitamin D supplementation modulates T cell-mediated immunity in humans: results from a randomized control trial”. The Journal of Clinical Endocrinology and Metabolism 2 (2020): 533-538.
  45. Martineau AR., et al. “Vitamin D supplementation to prevent acute respiratory tract infections; systematic review and meta-analysis of individual participant data”. BMJ (2017): i6583.
  46. Mousavi S., et al. “Immunomodulatory and antimicrobial effects of vitamin C”. European Journal of Microbiology and Immunology 9 (2019): 73-79.
  47. RML Colunga Biancatelli., et al. “The antiviral properties of vitamin C”. Expert Review of Anti-infective Therapy 18 (2020): 99-101.
  48. Grant WB., et al. “Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths”. Nutrients12 (2020): 988.
  49. Tian Y and Rong L. “Letter: Does vitamin d have a potential role againsts Covid-19? Authors reply”. Alimentary Pharmacology and Therapeutics 2 (2020): 410-411.


Citation: Mehtap Tınazli and Gaukhar Bakhtiyarova. “Relationship between Vitamin D Deficiency and Covid-19”.Acta Scientific Medical Sciences 7.10 (2023): 45-52.


Copyright: © 2023 Mehtap Tınazli and Gaukhar Bakhtiyarova. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US